Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BEN domain containing 3 pseudogene 1 (BEND3P1) is annotated as a human pseudogene species: BEND3P1 (Gene ID: 644459)[2][5]. Pseudogenes are generally classified as non-functional genomic elements derived from protein-coding genes through duplication or retrotransposition and usually do not encode active proteins[6]. BEND3P1 is homologous to BEN domain containing 3 (BEND3), a functional gene that encodes a transcriptional repressor with multiple BEN domains, known to mediate chromatin interactions and regulate transcription[1][3]. There is no credible scientific evidence that BEND3P1 directly encodes a functional gene product, acts as a therapeutic target, or interacts with known drugs. It is not described as a receptor, enzyme, transporter, transcription factor, or signaling molecule, and there is no information associating it with disease involvement or biomarker status. BEND3P1 can be distinguished from BEND3, which is a bona fide chromatin regulator and CpG island-binding protein involved in transcriptional repression during differentiation[1][3]. The designation "pseudogene" means BEND3P1 is typically considered non-functional, not a classical molecular target, and is not pursued in drug discovery or as a diagnostic marker. If detailed molecular target information is required, refer to BEND3 (BEN domain containing 3). In summary, BEND3P1 is mostly an annotated pseudogene of scientific record, not a druggable or functional target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BEN domain containing 3 pseudogene 1 (BEND3P1).